This precancerous condition can progress to active multiple myeloma, a type of blood cancer. High-risk ... Multiple Myeloma: Cilta-Cel Found Highly Effective in Real-World Study Oct. 4 ...

Multiple myeloma is a cancer of white blood cells in the bone marrow, responsible for producing antibodies, accounting for one to two per cent of all cancer cases. Globally, more than 170,000 ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

which are commonly used to manufacture protein-based drugs for treating cancer, ... New Innovative Local Treatment for Osteolytic Bone Disease in Multiple Myeloma Jan. 14, 2025 — A team of ...

The progression-free survival rate at 18 months was 62% across all dose levels and 70% among patients who received the phase 2 dosing regimen of talquetamab and teclistamab. The combination of ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

The establishment of the clinical laboratory aims to streamline the testing process for blood donors. Provided with modern ...

Partnerships provide spiritual growth today. Are your relational efforts paying off? Step back to see how far you’ve come. A higher understanding is beneficial as the sun coordinates with Neptune.

The American Cancer Society’s estimates for primary liver cancer and intrahepatic bile duct cancer in the United States for 2025 are: About 42,240 new cases (28,220 in men and 14,020 in women) will be ...

Many people have questions about how cancer can kill you. It is something that most people worry about at some point. We know that talking about this can be difficult. So, you can save to read this ...